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ABSTRACT
Objective: Quantifying residual volume contained in vials of antibiotics used in 
pediatrics. Method: This is an experiment involving samples from vials of antibiotics 
used in a pediatric hospital. Residual volume was identified by calculating the difference 
in weight measurement before and after the vials were washed. Evaluation of the residual 
volume difference in the vials was determined by the Wilcoxon non-parametric test for 
a sample and established at a significance level of 5%. Results: 105 samples of antibiotics 
were selected. The correct use of the antibiotics oxacillin (88.57%) and ceftriaxone 
(94.28%) predominated with low residual values. The same did not occur for procaine 
benzylpenicillin + potassium benzylpenicillin, since a greater residual volume was 
discarded in 74.28% of the vials. Conclusion: We highlight the need for improvements 
in managing antibiotics in the institution under study, so that the excess volume of the 
antibiotics in the vials is used within the acceptable stable time. It is also necessary that 
the disposal of the residual volume be adequately disposed, since it presents a risk to 
public health and the environment.
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INTRODUCTION
Among the drug classes, parenteral antibiotics are fre-
quently used in pediatrics(1). However, most drugs in the 
pharmaceutical market are not suitable for the pediatric age 
group, which often leads to the reuse of parenteral drugs in 
vials(2). This occurs because in the vast majority of cases, the 
dose the child needs is lower than the commercial quantity(3), 
so that there is residual volume remaining in the vials.
Furthermore, the practice of drug reconstitution(2) is often 
required as a consequence of the lack of pediatric formula-
tions, where part of a solid form is added with sterile water for 
injectable or physiological solutions to result in a liquid form. 
Dilution is also common, where the concentrated liquid form 
added to the sterile water for injections or to physiological 
solution results in a more diluted liquid form(4).
Reusing medication in vials, commercial quantity medi-
cation dose, and the intended dose in the therapeutic regi-
men are of crucial importance in determining the residual 
volume(5), which is the volume that remains in the vial after 
drug reconstitution, dilution and administration.
Upon perceiving that there is a residual volume of the 
drug after its reconstitution and administration in the case of 
vials with multiple doses, it is necessary to take into account 
the correct use of the maximum possible amount of the 
antibiotics, respecting the stability time after reconstitution 
and dilution(2).
Moreover, the presence of residue in the packages, in 
addition to increasing hospital costs(5) also implies the need 
for correct disposal, otherwise the residues pose a risk to 
public health and to the environment(6).
In view of the above, the following question was raised: 
During the preparation of parenteral antibiotics used in 
pediatrics, is there excess medication remaining in the vials?
This study is relevant as it investigates the correct use 
of antibiotics in vials, which is influenced by appropriate 
conservation, dilution and administration(7).
Questions within the context of patient safety are a 
matter of prominence and worldwide relevance, and aim 
to prevent harm due to inadequate techniques. Moreover, a 
broader perspective focused on health promotion provides 
empowerment and autonomy to professionals.
The purpose of this study was to quantify the residual 
volume contained in vials of antibiotics used in pediatrics.
METHOD
An experimental cross-sectional study conducted at the 
pharmacotechnical laboratory of the Universidade Federal 
do Ceará, in January 2016.
Vials of antibiotics after reconstruction and administra-
tion (of the content) to children of a hospital in Fortaleza, 
Ceará state which were destined to disposal were collected 
in order to obtain the data. This was conducted with autho-
rization from the health institution and after authorization 
from the Research Ethics Committee of the Universidade 
Federal do Ceará, with protocol approval number 954.076. 
The study institution was chosen for being a specialized and 
municipal reference in pediatric care.
This institution has a standardized protocol for the 
reconstitution of injectable antibiotics which is performed 
by the nursing team. Regarding the drugs selected for the 
study, and according to hospital standardization, reconsti-
tution was performed as follows: 5 mL of distilled water 
for 500 mg oxacillin, 2 mL of distilled water for procaine 
benzylpenicillin (300,000 IU) + potassium benzylpenicil-
lin (100,000 IU), and 10 mL of distilled water for 1 g of 
intravenous ceftriaxone.
Inclusion criteria for selecting each vial assigned for 
disposal were: having been reconstituted according to the 
hospital standardization; it contained identification with the 
date and time of preparation and dilution; it was at most 48 
hours before the residual volume analysis; and it had no signs 
of residue degradation, such as color change or precipitate 
formation. A total of 186 vials of antibiotics were collected; 
however, analysis of the residual volume was carried out using 
105 vials, since the others did not have the date and time 
identification of the dilution, or showed signs of residue deg-
radation and/or precipitation. It is worth mentioning that the 
vials under study came from different laboratories.
In order to quantify the residue contained in the vials 
of the antibiotics after reconstitution, recommendations for 
the method of checking the excess volume recommended for 
injectable liquids contained in the Brazilian Pharmacopoeia 
were adapted, and all the necessary steps were performed, 
namely: 1 – Removing metal seals; 2 – Removing labels that 
could be damaged during the test; 3 – Individual weighing of 
each vial with its respective cap using an analytical balance 
(with precision of 0.1 mg); 4 – Removing vial contents; 5 – 
Washing vials and caps with 6% hydrogen peroxide solution, 
running water and distilled water; 6 – Drying in oven at 
105ºC for at least one hour, or at a temperature compatible 
with the vial material; 7 – Cooling at room temperature; 8 
– Placing vial caps back on; 9 – Performing a new weighing 
of the vials and cap together(4).
The form used in this study was developed by the 
researchers and it included the following data: name of the 
antibiotic, presentation/appearance, date of preparation and 
dilution, weight values before and after removing the vial 
contents, records of the weight difference for determining 
the residual volume of each vial.
All the steps of the study were followed by the pharma-
ceutical researcher responsible for the laboratory, and the 
experiments were carried out by two researchers. Firstly, at 
the end of the morning shift the researchers collected the 
vials destined to be discarded at the hospital, obeying the 
stability time of each one. The vials were then taken to the 
laboratory and the steps for measuring the residual volume 
were initiated. The samples were collected at the hospital 
for eight days in order to obtain a larger number of samples 
and for the convenience of the analyzers.
The pharmacotechnics laboratory only has one entrance 
with a height of 4 meters, lighting with fluorescent lamps 
without the incidence of direct sunlight, and temperature 
maintained by a split air conditioner regulated to 22ºC with 
relative humidity around 50%. The drugs were separated 
by antibiotic class and the labels were removed. Next, vials 
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and caps were numbered and weighed using an accurately-
calibrated and precision-tested PRECISA 205ASCS® ana-
lytical balance, which was turned on 30 minutes before the 
start of the analyzes.
After weighing the containers with the drug residue, 
vials and caps were separated and sequentially washed with 
6% hydrogen peroxide solution, running water and distilled 
water. The residues were removed using a wash bottle to 
shoot distilled water directly into the entire interior of the 
vial, and to wash the inside of the lid. The residue obtained 
from the wash was collected, treated with hydrogen peroxide 
and then discarded.
At the end of this process, the vials were inspected to 
identify any fragment of adhered antibiotic that might not 
have been removed with the washing steps described above; 
in this case, the washing would be repeated until fragments 
were completely removed. The material was dried in an 
oven at 105°C for about six hours (to avoid the presence of 
liquid or moisture in the flask) and weighed again using the 
same analytical balance. The difference between the initial 
weight and the final weight represents the residue weight 
contained in each vial.
The results of the residual volumes of each vial were 
tabulated in Excel spreadsheets (Windows, 2010) and ana-
lyzed by software R, version 3.2.2. Data analysis was based 
on descriptive statistics with measures of central tendency 
and dispersion such as mean, median and standard deviation. 
Evaluation of the difference in residual volumes in the vials 
was determined by the Wilcoxon non-parametric test for a 
sample, establishing a level of significance of 5%.
RESULTS
The therapeutic classes of the 105 antibiotics selected 
for the study were as follows: Penicillins represented by 
oxacillin (500 mg), procaine benzylpenicillin (300,000 IU) 
+ potassium benzylpenicillin (100,000 IU), and third gen-
eration cephalosporin represented by ceftriaxone (1 g), with 
35 samples of each.
The choice for the antibiotics analyzed in the study was 
determined by the fact that they were standardized in the 
hospital and due to their frequent use in the pediatric popu-
lation. The manufacturer of each vial was not identified, as 
the focus of our study was to demonstrate the quantification 
of residue leftover after reconstitution of the antibiotic, and 
the importance of using it as much as possible, regardless 
of the drugs being manufactured by different laboratories.
We found that the amount of the oxacillin and ceftriax-
one antibiotics analyzed in the vials presented lower residual 
values than those obtained from most procaine benzylpeni-
cillin + potassium benzylpenicillin vials (Table 1).
Residual volume values(4) shown in Table 1 are the same 
as in Table 2, and were used as limits due to the lack of 
specific reference regarding the amount of medicine that 
may remain in the vial after reconstitution and administra-
tion steps.
Table 2 shows the median weight in grams before and 
after washing, and mean residual weight of each antibiotic. 
Note that oxacillin and ceftriaxone antibiotics presented 
lower residual volumes than those observed for the procaine 
benzylpenicillin + potassium benzylpenicillin antibiotic.
Table 1 – Number of analyzed vials (N) according to the residual volume limit for each type of antibiotic – Fortaleza, Ceará, Brazil, 2016
Residual Volume (ml) n %
Oxacillin
< 0.3 31 88.57
> 0.3 4 11.42
Procaine benzylpenicillin + potassium benzylpenicillin
< 0.15 9 25.71








Source: Research Data (2016).
Table 2 – Measures of central tendency of the weights (in grams) before and after washing, residual volume (mL) of antibiotics in vials 
and recommended volume (mL) – Fortaleza, Ceará, Brazil, 2016.
Antibiotic
Median and standard 
deviation
Weight before (g)
Median and standard 
deviation
Weight after (g)









18.84±0.5253 18.57±0.295 0.2288±0.307 0.15
Ceftriaxone 23.92±0.7011 23.62±0.712 0.1719±0.015 0.5
Source: Research data (2016). Brazilian Pharmacopeia(4).
4 www.ee.usp.br/reeusp
Residual volume in vials of antibiotics used in pediatrics
Rev Esc Enferm USP · 2017;51:e03234
A statistically significant difference was found from the 
results obtained in the Wilcoxon test for the three groups 
of analyzed antibiotics, with p=2.257 x 10-9 for oxacillin, 
p=5.452 x 10-5 for procaine benzylpenicillin + potassium 
benzylpenicillin, and p=1.879 x 10-5 for ceftriaxone.
Despite not being the objective of the study, it was also 
observed that the nursing team discarded the vials of diluted 
antibiotics after the end of the shift before its acceptable 
stability time, without using all.
These residues were discarded without performing mea-
sures to inactivate leftover antibiotics in vials; this being 
divergent practice from legal provisions, raising a worrying 
concern for our clinical practice on how and where this waste 
is being disposed.
DISCUSSION
The types of analyzed antibiotics are in line with the pro-
file of the most commonly used antimicrobials in a pediatric 
unit described in the scientific literature, such as ceftriaxone, 
cephalexin, gentamicin, ampicillin, oxacillin and procaine 
penicillin G(7).
Although the present study did not evaluate the prepa-
ration and administration of the antibiotics by the nursing 
team, the residual volume findings in the vials of oxacillin 
and ceftriaxone antibiotics represent the correct use and 
dilution of these drugs. In view of the complexity of par-
enteral administration, this is a positive factor due to the 
significant error rate related to this route(8-9).
However, the fragility of the medication system is per-
ceived as evidenced by the frequent doubts of the nurs-
ing team regarding drug preparation and administra-
tion(10). Thus, we highlight the need for professionals to 
have knowledge and access to drug information centers of 
the local universities, such as the Medicine Information 
Center of the Pharmacy Department of the Universidade 
Federal  do Ceará.
Higher residual weight averages in the vials of the 
antibiotic procaine benzylpenicillin + potassium benzyl-
penicillin may have been influenced by the recommended 
dosage including longer time intervals, which makes it 
more difficult to reuse them, unlike the other antibiotics 
analyzed in the present study. The dosage for children is 
reduced and quite variable compared to that of an adult, 
leading to greater leftover antibiotics and thus a consequent 
increase  in its waste.
These results reinforce the importance of using the 
volume contained in the vials to its maximum after recon-
stitution; in other words, the residual content in the vial 
should be used if within the acceptable stability time 
and maintained at the appropriate temperature until its 
full usefulness, regardless of the change in shifts of nurs-
ing professionals.
An observational study that analyzed aspects related to 
reconstitution, storage, temperature and labeling of medi-
cines in vials in a pediatric unit found that from a total of 
44 vials, only three contained all identifying items recorded 
on the label, posing a risk to the safety of its reuse(2).
The residual volume results found still raise concerns 
about antibiotic management in the institution under study. 
It is worth mentioning that drug management programs 
have been implemented throughout many European hos-
pitals, but nurse involvement has been limited even though 
it is described as being multidisciplinary in approach, which 
is due to the workload and high turnover of nursing staff (11).
Medication management depends on correct medical 
prescription, dispensing, preparation and administration 
aimed at the rational use of medicine. Losses should be 
continuously avoided under penalty of being harmful to 
collective health and also to public funds(12).
As the most consistent bedside care providers, nurses 
have an ideal position to improve antibiotic management 
through multidisciplinary collaboration, optimizing treat-
ment, monitoring and administration, while improving 
pediatric patient safety and quality of care(11).
The lack of parenteral drugs in adequate presentation 
for pediatrics represents a worldwide problem, constituting 
one of the factors that most contributes to the reuse of these 
medicines and also to increased care costs(13-14).
The waste of antibiotics evidenced by the existence of 
residual volume reinforces another worrying finding, which 
is the inadequate disposal of the vials containing residual 
volumes of medicines. Such disposal represents a potential 
risk of contributing to antimicrobial resistance(15), which is a 
threat to patient safety around the world(16). Nurses also play 
an important role in the management of waste disposal, which 
may pose a risk to public health and to the environment(17).
Waste disposal in the hospital area is framed in the tech-
nical regulation described by Resolution 306/2004 of the 
National Agency of Sanitary Surveillance on waste man-
agement of public and private health services, as well as by 
Resolution 358/2005 of CONAMA (Conselho Nacional do 
Meio Ambiente), which deals with the treatment and disposal 
of waste from health services(17-18).
CONCLUSION
Oxacillin and ceftriaxone antibiotics presented residual 
volumes represented by the correct use and dilution of these 
drugs by the nursing team. In contrast, a higher residual 
volume was found in the vials of procaine benzylpenicillin 
+ potassium benzylpenicillin antibiotics.
The residual volume results are worrisome due to inad-
equate disposal of the vials containing residual medicine 
volumes; this represents a potential risk of contribut-
ing to antimicrobial resistance, as well as the need for 
improving the management of antibiotics in the institution 
under study.
Although the study presents limitations as it was carried 
out in only one pediatric health institution, the scientific 
findings presented contribute to nurses for providing safe 
and quality care to children using medication treatment.
We also emphasize the importance of discussing antibi-
otic preparations adapted for use in the pediatric population, 
which constitutes as a challenge in Nursing.
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RESUMO
Objetivo: Quantificar o volume residual contido em frascos-ampola de antibióticos utilizados na pediatria. Método: Trata-se de um 
experimento com amostras de frascos-ampola de antibióticos utilizados em hospital pediátrico. O volume residual foi identificado 
calculando-se a diferença da aferição do peso antes e após a lavagem do frasco-ampola. A avaliação da diferença dos volumes residuais 
nos frascos-ampola foi determinada pelo teste não paramétrico de Wilcoxon para uma amostra e estabelecido o nível de significância 
de 5%. Resultados: Foram selecionadas 105 amostras de antibióticos. Predominou o correto aproveitamento dos antibióticos oxacilina 
(88,57%) e ceftriaxona (94,28%), com baixos valores residuais. O mesmo não ocorreu com a benzilpenicilina procaína + potássica, pois 
em 74,28% dos frascos houve descarte de volume residual superior. Conclusão: Destaca-se a necessidade de melhorias na gestão dos 
antibióticos na instituição em estudo, para que o volume excedente do antibiótico em frasco-ampola seja aproveitado até o tempo de 
estabilidade permitido, assim como é necessário que haja a adequação da forma de descarte do volume residual, que apresenta risco à 
saúde pública e ao meio ambiente.
DESCRITORES
Volume Residual; Antibacterianos; Infusões Parenterais; Enfermagem Pediátrica.
RESUMEn
Objetivo: Cuantificar el volumen residual contenido en frascos-ampolla de antibióticos utilizados en pediatría. Método: Se trata de 
un experimento con muestras de frascos-ampolla de antibióticos utilizados en hospital pediátrico. El volumen residual fue identificado 
calculándose la diferencia de la verificación del peso antes y después del lavado del frasco-ampolla. La evaluación de la diferencia de los 
volúmenes residuales en los frascos-ampolla fue determinada por la prueba no paramétrica de Wilcoxon para una muestra y establecido 
el nivel de significación del 5%. Resultados: Fueron seleccionadas 105 muestras de antibióticos. Predominó el correcto aprovechamiento 
de los antibióticos oxacilina (88,57%) y ceftriaxona (94,28%), con bajos valores residuales. Lo mismo no ocurrió con la bencilpenicilina 
procaína + potásica, pues en el 74,28% de los frascos hubo descarte de volumen residual superior. Conclusión: Se destaca la necesidad 
de mejorías en la gestión de los antibióticos en la institución en estudio, a fin de que el volumen excedente del antibiótico en frasco-
ampolla se aproveche hasta el tiempo de estabilidad permitido, así como es necesario que haya la adecuación de la manera de descarte 
del volumen residual, que presenta riesgo a la salud pública y al medio ambiente.
DESCRIPTORES
Volumen Residual; Antibacterianos; Infusiones Parenterales; Enfermería Pediátrica.
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